Search PubMed⌕ Search

Biomedical subjects

I Jalsenjak

Publications and source records attributed to I Jalsenjak.

28 records · Page 2Linked to original sources
PubMed1977

Dissolution from tablets prepared using ethyl cellulose microcapsules.

Microcapsules containing sodium phenobartitone cores in ethyl cellulose have been used to prepare tablets at from 3-9 to 358-9 MPa compression pressures. The tensile strength of these tablets is related linearly to the core: wall ratio and to the microcapsule size. Dissolution of the drug from the microcapsules, is also related to the core:wall ratio and microcapsule size, but except at low compression pressures is almost independent of the pressure used during preparation. The tablet matrix remains intact during the dissolution and the equations developed by Schwartz, Simonelli & Higuchi (1968) are followed. Large microcapsules 1:2 core: wall ratio produce friable tablets with rapid release of contents.

Capsules↗
PubMed1976

The in vitro dissolution of phenobarbitone sodium from ethyl cellulose microcapsules.

Microcapsules of sodium phenobarbitone, with a wall of ethyl cellulose, have been prepared. The size distribution was determined by use of standard sieves and the effect of coreWALL ratio noted. Release of the drug into an aqueous medium was studied. The release pattern was found to have similar characteristics to the release of a drug from an insoluble porous matrix.

Capsules↗
PubMedDate not supplied

Mucoadhesive chitosan-coated liposomes: characteristics and stability.

Lecithin liposomes, empty or containing FITC-dextran, were prepared by the ethanol injection method. Three different types of chitosans with different molecular weight and degrees of deacetylation were used (Seacure 113, 210 and 311). Chitosan coating was carried out by mixing the liposomal suspension with the chitosan solution followed by incubation. The size of liposomes was measured before and after polymer coating by an image analysis technique. The mean diameter of liposomes containing FITC-dextran was in the size range 250-280 nm, whereas the size after coating was 300-330 nm, regardless of chitosan type. All chitosan-coated liposomes were of spherical shape and no morphological differences between uncoated and coated liposomes were observed. Liposomes with FITC-dextran, originally entrapping 50% of the marker substance taken in the preparation and coated in the presence of unentrapped marker substance, contained 60-65% of the marker substance. The highest entrapment was found for liposomes coated with medium molecular weight chitosan. The stability of chitosan-coated liposomes in simulated gastric fluid was significantly higher as compared to uncoated liposomes. One can conclude that chitosan is stabilizing the original liposomal structure and protecting liposomally entrapped drug.

Adhesives↗
PubMedDate not supplied

Poly(lactic acid) microencapsulated oxytetracycline: in vitro and in vivo evaluation.

Poly(lactic acid) microcapsules of oxytetracycline hydrochloride were prepared by precipitation of the polymer from a solution when a non-solvent was added to a polymer solution in which the drug had been dispersed. Three types of microcapsules were prepared by varying the amount of drug encapsulated, as well as by using two samples of polymer with different molecular weights. The product obtained was of a matrix character consisting of agglomerated capsules. The drug release in vitro, for the best batch, was completed within 12 hours. Serum levels of the drug in rabbits treated by intramuscular injection were prolonged maximally up to 24 hours depending upon the type of microcapsules.

Animals↗
PubMedDate not supplied

Influence of the atomization time on the properties of ethylcellulose microcapsules of isoniazid prepared by a fluidized bed.

Microcapsules containing isoniazid were produced by the fluidized bed method with ethylcellulose by varying the total atomization time. The kinetics of capsules growth during the preparation was discussed on the basis of the distribution of particle size. The quality of the capsules was evaluated using the particle size characteristics, the total content of ethylcellulose, the particle and wall density, and the time needed for the 50 per cent release of the drug. An increase in the atomization time of the ethylcellulose solution gave rise to an increase in the mean diameter of particles and the ethylcellulose content of capsules; it also produced a more dense product with a prolonged release of the drug. The release of the drug from tabletted microcapsules was further prolonged.

Aerosols↗
PubMedDate not supplied

Microencapsulated monosialoganglioside GM1: physical properties and in vivo effects.

The prevention of the decrease of choline acetyltransferase (ChAT) enzymatic activity was achieved by applying GM1 in an animal model for studying retrograde degenerations of cholinergic neurons. Devascularizing lesions of the rat cortex led to a significant decrease in activity of ChAT in the nucleus basalis magnocellularis (NBM), but this decrease was effectively prevented by GM1 administration either centrally or locally in a microencapsulated form. Compared with the relatively large dose of GM1 which has to be given when the drug is administered. i.p. microencapsulated GM1 applied locally and directly over the lesioned cortical surface seems to be effective in much lower doses.

Animals↗
PubMedDate not supplied

Microparticles with neuroactive agents.

An overview of biodegradable and biocompatible microcapsules and microspheres loaded with neuroactive substances, or cells producing neuroactive substances, and their role as drug delivery systems (DDS) for drug administration to the central nervous system (CNS) is given. In addition, closely related systems are also summarized.

Animals↗
PubMedDate not supplied

Permeability to solutes of polyamide capsules with different chemical compositions.

The permeability of nylon capsule membranes with different chemical compositions to solutes was studied at different temperatures. The rate of solute permeation through the membrane decreased with increasing hydrophobicity of the membrane in the temperature range of 293-323 K. Increase in the size of permeant molecules caused a decreased in their rate of permeation through all capsule membranes at all temperatures studied. Higher permeation rates were observed for all permeants at higher temperatures. The activation energy of permeation was evaluated for the permeants from the Arrhenius plots of their permeation data. From the values of activation energy evaluated the solute permeation through the nylon capsule membranes was demonstrated to proceed by a pore mechanism.

Capsules↗
PubMedDate not supplied

Fluid-bed microencapsulation of ascorbic acid.

Ascorbic acid has been fluidized and microencapsulated with three different hydrophobic coating materials by the top-spray method. The experiments were conducted with polymethacrylate coating material formulated as a water dispersion, and ethyl-cellulose and waxy coating material both formulated as organic solutions. Characteristics of the fluidized bed procedure in conical geometry have been determined by estimation of two parameters: bed porosity and total pressure drop. A satisfactory agreement between experimental and calculated values has been reached. The following properties of the microencapsulated ascorbic acid have been determined: core content, bulk and tapped density, crystal size distribution prior and after microencapsulation, surface morphology and release profile. The comparison and evaluation of different hydrophobic coating materials have been performed on the basis of these findings.

Ascorbic Acid↗